DXCM vs GATX · P/E 63, rev $2.50B vs P/E 19, rev $1.16B
DexCom Inc (DXCM) versus GATX Corporation (GATX) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
GATX Corporation (GATX) is a rental & leasing services company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported GATX revenue for 2026-06-30 was $1.16B. Net income was $188.9M. Revenue was up 99.4% from 2026-03-31 to 2026-06-30. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. GATX currently screens at market cap $6.23B and trailing P/E 18.8.
Not investment advice. Open the DXCM and GATX stock pages for the full models.
Not investment advice.